Paul Goode
Vermögen: 224 $ am 31.05.2026
Vermögen: 224 $ am 31.05.2026
Dr. Paul V.
Goode is a President, Chief Executive Officer & Director at GlucoTrack, Inc. He is on the Board of Directors at GlucoTrack, Inc. Dr. Goode was previously employed as a Chief Executive Officer by EndoStim, Inc., a Vice President-Research & Development by MetaCure (USA), Inc., an Engineering Director by Impulse Dynamics (USA), Inc., an Engineering Director by DexCom, Inc., a Principal by Guidant Corp., a Principal by Intermedics, Inc., a Senior Engineer by MiniMed, Inc., and a Vice President-Product Development by Orchestra BioMed, Inc. He also served on the board at A.D.
Integrity Applications Ltd. and Elira, Inc. He received his undergraduate degree from North Carolina State University, a graduate degree from North Carolina State University and a doctorate degree from North Carolina State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GLUCOTRACK INC 0,01 % | 28.01.2026 | 339 ( 0,01 % ) | 224 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| GLUCOTRACK, INC. | Vorstandsvorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ENDOSTIM INC | Vorstandsvorsitzender | 01.07.2019 |
MetaCure (USA), Inc.
MetaCure (USA), Inc. Pharmaceuticals: MajorHealth Technology Provides invasive treatment for diabetes | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 |
Impulse Dynamics (USA), Inc.
Impulse Dynamics (USA), Inc. Medical SpecialtiesHealth Technology Develops implantable device for the treatment of chronic heart failure | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 |
| DEXCOM, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 |
A.D. Integrity Applications Ltd.
A.D. Integrity Applications Ltd. Medical SpecialtiesHealth Technology Develops a non-invasive glucose monitoring device | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
MiniMed, Inc.
MiniMed, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures, and distributes advanced infusion systems | Health Technology |
EndoStim, Inc.
EndoStim, Inc. Medical SpecialtiesHealth Technology Develops electro medical devices to treat gastrointestinal neuromuscular disorders | Health Technology |
GlucoTrack, Inc.
GlucoTrack, Inc. Medical SpecialtiesHealth Technology Develops a non-invasive glucose monitoring device | Health Technology |
DexCom, Inc.
DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MetaCure (USA), Inc.
MetaCure (USA), Inc. Pharmaceuticals: MajorHealth Technology Provides invasive treatment for diabetes | Health Technology |
Intermedics, Inc.
Intermedics, Inc. Medical SpecialtiesHealth Technology Develops and markets complex devices for treating malfunctions of the heart | Health Technology |
Elira, Inc.
Elira, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
A.D. Integrity Applications Ltd.
A.D. Integrity Applications Ltd. Medical SpecialtiesHealth Technology Develops a non-invasive glucose monitoring device | Health Technology |
Orchestra BioMed, Inc.
Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Develops transformative therapeutic products | Health Technology |
Impulse Dynamics (USA), Inc.
Impulse Dynamics (USA), Inc. Medical SpecialtiesHealth Technology Develops implantable device for the treatment of chronic heart failure | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen